106 related articles for article (PubMed ID: 9302180)
1. Numerical chromosomal aberrations in transition-zone carcinomas of the prostate.
Erbersdobler A; Hammerer P; Huland H; Henke RP
J Urol; 1997 Oct; 158(4):1594-8. PubMed ID: 9302180
[TBL] [Abstract][Full Text] [Related]
2. Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour.
Shannon BA; McNeal JE; Cohen RJ
Pathology; 2003 Dec; 35(6):467-71. PubMed ID: 14660095
[TBL] [Abstract][Full Text] [Related]
3. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
Steuber T; Karakiewicz PI; Augustin H; Erbersdobler A; Lange I; Haese A; Chun KH; Walz J; Graefen M; Huland H
J Urol; 2005 Mar; 173(3):737-41. PubMed ID: 15711259
[TBL] [Abstract][Full Text] [Related]
4. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
5. Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma.
Henke RP; Hammerer P; Graefen M; Erbersdobler A; Neumann M; Berger J; Huland H
Cancer; 1998 Sep; 83(5):977-88. PubMed ID: 9731903
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
7. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
9. Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.
Augustin H; Erbersdobler A; Graefen M; Fernandez S; Palisaar J; Huland H; Hammerer P
Prostate; 2003 Apr; 55(1):48-54. PubMed ID: 12640660
[TBL] [Abstract][Full Text] [Related]
10. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
[TBL] [Abstract][Full Text] [Related]
11. Numerical chromosomal changes in high-grade prostatic intraepithelial neoplasia (PIN) and concomitant invasive carcinoma.
Erbersdobler A; Gürses N; Henke RP
Pathol Res Pract; 1996 May; 192(5):418-27. PubMed ID: 8832746
[TBL] [Abstract][Full Text] [Related]
12. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.
Noguchi M; Stamey TA; Neal JE; Yemoto CE
J Urol; 2000 Jun; 163(6):1751-5. PubMed ID: 10799175
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
[TBL] [Abstract][Full Text] [Related]
14. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
Chun FK; Briganti A; Jeldres C; Erbersdobler A; Schlomm T; Steuber T; Gallina A; Walz J; Perrotte P; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2007 Apr; 51(4):949-55; discussion 955. PubMed ID: 16904818
[TBL] [Abstract][Full Text] [Related]
15. Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland?
Grignon DJ; Sakr WA
J Cell Biochem Suppl; 1994; 19():267-9. PubMed ID: 7823599
[TBL] [Abstract][Full Text] [Related]
16. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.
Greene DR; Taylor SR; Wheeler TM; Scardino PT
Cancer Res; 1991 Aug; 51(15):4084-9. PubMed ID: 1855223
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
19. Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker.
Wilson MJ; Haller R; Li SY; Slaton JW; Sinha AA; Wasserman NF
J Urol; 2005 Sep; 174(3):1124-8. PubMed ID: 16094078
[TBL] [Abstract][Full Text] [Related]
20. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology.
Bouyé S; Potiron E; Puech P; Leroy X; Lemaitre L; Villers A
Prostate; 2009 Jan; 69(1):105-13. PubMed ID: 18850578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
